The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants

Journal of Perinatology

Volumn 27, Issue 1, 2007, Pages 22-27

  Cordero, Leandro ^a   Nankervis, C A ^a   Gardner, D ^a   Giannone, P J ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; STEROID;

ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CESAREAN SECTION; CHEMOPROPHYLAXIS; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG EXPOSURE; DRUG RESPONSE; DRUG USE; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GENDER; GESTATIONAL AGE; HUMAN; INFANT; INFANT MORTALITY; LIGATION; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; POSTNATAL CARE; PREECLAMPSIA; PREMATURE LABOR; PRENATAL PERIOD; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; TOCOLYSIS; TREATMENT DURATION; TREATMENT RESPONSE;

DUCTUS ARTERIOSUS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INDOMETHACIN; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; PREGNANCY; TOCOLYSIS; TOCOLYTIC AGENTS;

EID: 33845731249     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211612     Document Type: Article

References (26)

1. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: Pathophysiology and management. J Perinatol 2006; 26: S14-S18.
2. Clyman RI. Recommendations for the postnatal use of indomethacin: An analysis of four separate treatment strategies. J Pediatr 1996; 128: 601-607.
3. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth might of 1000 grams or less. Pediatrics 2006; 117: 1113-1121.
4. Schmidt B, Davis P, Modemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 1966-1972.
5. Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants; a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2003; 88: F464-F466.
6. Narayanan M, Cooper B, Weiss H, Clyman RI. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr 2000; 136: 330-337.
7. Norton M, Merrill J, Cooper B, Kuller J, Clyman R. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329: 1602-1607.
8. Souter D, Harding J, McCowan L, O'Donnell C, McLeay E, Baxendale H. Antenatal indomethacin - adverse fetal effects confirmed. Aust NZ J Obstet Gynaecol 1998; 38: 11-16.
9. Hammerman C, Glaser J, Kaplan M, Schimmel M, Ferber B, Eidelman A. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics 1998; 102: 1-4.
10. Suarez VR, Thompson LL, Jain V, Olson GL, Hankins GDV, Belfort MA et al. The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate. Am J Obstet Gynecol 2002; 187: 886-888.
11. Vermillion ST, Landen CN. Prostaglandin inhibitors as tocolytic agents. Semin Perinatol 2001; 25: 256-262.
12. Iams JD, Creasy RK. Preterm labor and delivery In: Creasy RJ, Resnik R, Iams JD (eds). Maternal-Fetal Medicine: Principles and Practice. 5th edn Saunders: Philadelphia, PA, 2004, p 623-651.
13. Loe S, Sanchez-Ramos L, Kaunitz A. Assessing the neonatal safety of indomethacin tocolysis: A systematic review with meta-analysis. Obstet Gynecol 2005; 106: 173-179.
14. Van Den Veyver IB, Moise KJ, Ou C, Carpenter RJ. The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus. Obstet Gynecol 1993; 82: 500-503.
15. Vermillion S, Scardo J, Lashus A, Wiles H. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 1997; 177: 256-261.
16. Abbasi S, Gerdes JS, Sehdev HM, Samimi SS, Ludmir J. Neonatal outcome after exposure to indomethacin in utero: A retrospective case cohort study. Am J Obstet Gynecol 2003; 189: 782-785.
17. Papile LA, Burstein J, Burstein R, Koffler H. incidence and evolution of the subependymal intraventricular hemorrhage: A study of infants with weights less than 1500 g. J Pediatr 1978; 92: 529-534.
18. Macones GA, Marder SJ, Clothier B, Stamilio DM. The controversy surrounding indomethacin for tocolysis. Am J Obstet Gynecol 2001; 184: 264-272.
19. Ojala R, Ikonen S, Tammela O. Perinatal indomethacin treatment and neonatal complications in preterm infants. Eur J Pediatr 2000; 159: 153-155.
20. Gardner MO, Owen J, Skelly S, Hauth JC. Preterm delivery after indomethacin: A risk factor for neonatal complications? J Reprod Med 1996; 41: 903-906.
21. Doyle NM, Gardner MO, Wells L, Qualls C, Papile LA. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis. J Perinatol 2005; 25: 336-340.
22. Tyson JE, Younes J, Verter J, Wright LL. Viability, morbidity, and resource use among newborns of 501-800 g birth weight. JAMA 1996; 276: 1645-1651.
23. Attridge JT, Clark R, Walker MW, Gordon PV. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006; 26: 93-99.
24. Clyman RI, Chen YQ, Chemtob S, Mauray F, Kohl T, Varma DR et al. In utero remodeling of the fetal lamb ductus arteriosus: The role of antenatal indomethacin and a vascular zone thickness on vasa basorum proliferation, neointima formation, and cell death. Circulation 2001; 103: 1806-1812.
25. Clyman RI, Chan CY, Mauray F, Chen YQ, Cox W, Seidner SR et al. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia and gestation. Pediatr Res 1999; 45: 19-29.
26. Weiss H, Cooper B, Brook M, Schlueter M, Clyman R. Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr 1995; 127: 466-471.